The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation

European Journal of Endocrinology

Volumn 158, Issue 1, 2008, Pages 77-83

  Phan, Ha T T ^a   Jager, Pieter L ^c   van der Wal, Jacqueline E ^b   Sluiter, Wim J ^a   Plukker, John T M ^a   Dierckx, Rudi A J O ^a   Wolffenbuttel, Bruce H R ^a   Links, Thera P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Pathology   (Netherlands)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RADIOISOTOPE THERAPY; RECURRENT CANCER; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHEMILUMINESCENT MEASUREMENTS; DISEASE PROGRESSION; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 38949216766     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0399     Document Type: Article

References (23)

1. Herle van AJ, Vassart G & Dumont JE. Control of thyroglobulin synthesis and secretion (second of two parts). New England Journal of Medicine 1979 301 307-314.
2. Spencer CA & Wang CC. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Endocrinology and Metabolism Clinics of North America 1995 24 841-863.
3. Demers CM & Spencer CA (Eds). National Academy of Clinical Biochemistry Laboratory support for the diagnosis and monitoring of thyroid disease. Available at: http://www.nacb.org/lmpg/ thyroid_lmpg_pub.stm, 2002.
4. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS & Nicoloff JT. Serum thyroglobulin antibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism 1998 83 1121-1127.
5. Grant S, Luttrell B, Reeve T, Wiseman J, Wilmshurst E, Stiel J, Donohoe D, Cooper R & Bridgman M. Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma. Cancer 1984 54 1625-1628.
6. Westbury C, Vini L, Fischer C & Harmer C. Recurrent differentiated thyroid cancer without elevation of serum thyroglobutin. Thyroid 2000 10 171-175.
7. Mertens IJ, De Klerk JM, Zelissen PM, Thijssen JH, Sie-Go DM, Han SH & Van Rijk PP. Undetectable serum thyrogtobulin in a patient with metastatic follicular thyroid cancer. Clinical Nuclear Medicine 1999 24 346-349.
8. Brendel AJ, Lambert B, Guyot M, Jeandot R, Dubourg H, Roger P, Wynschauk S, Manciet G & Lefort G. Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow-up of differentiated thyroid carcinoma. European Journal of Nuclear Medicine 1990 16 35-38.
9. Gibelli B, Tredici P, De Cicco C, Bodei L, Sandri MT, Renne G, Bruschini R & Tradati N. Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin. Acta Otorhinolaryngologica Italica 2005 25 94-99.
10. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D'Azzo G, Meringolo D, Ferretti E, Sacco R, Arturi F & Filetti S. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. Journal of Clinical Endocrinology and Metabolism 2004 89 3402-3407.
11. Schlumberger M. Papillary and follicular thyroid carcinoma. New England Journal of Medicine 1998 338 297-306.
12. 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. European Journal of Endocrinology 2003 148 19-24.
13. Bachelot A, Cailleux AF, Klain M, Baudin E, Ricard M, Bellon N, Caillou B, Travagli JP & Schlumberger M. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 2002 12 707-711.
14. Bachelot A, Leboulleux S, Baudin E, Hartl DM, Caillou B, Travagli JP & Schlumberger M. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment. Clinical Endocrinology 2005 62 376-379.
15. 131I with regard to surgery in patients with differentiated thyroid carcinoma. Cancer 2005 10 59-67.
16. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, & Morrow M (Eds). AJCC Cancer Staging Manual edn 6. Philadelphia: Lippincott-Raven, 2002.
17. Links TP, van Tol KM, Jager PL, Piers DA, Boezen HM, Dullaart RP, de Vries EG & Sluiter WJ. life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocrine-Related Cancer 2005 12 273-280.
18. Persoon AC, van den Ouweland JM, Wilde J, Kema IP, Wolffenbuttel BH & Links TP. Clinical utility of an automated immunochemiluminometric thyroglobulin assay in differentiated thyroid carcinoma. Clinical Chemistry 2006 52 686-691.
19. Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlageter ME, Claustrat F, Koscielny F, Taieb D, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Torlontano M, Tenenbaum F, Bardet S, Bussiere F, Girard JJ, Morel O, Schneegans O, Schlienger JL, Prost A, So D, Archambaud F, Ricard M & Benhamou E. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. Journal of Clinical Endocrinology and Metabolism 2007 10 2487-2495.
20. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S & LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism 2005 90 5566-5575.
21. Giovanella L, Ceriani L, Ghelfo A, Maffioli M & Keller L. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management trategy. Clinical Endocrinology 2007 67 547-551.
22. Iervasi A, Iervasi G, Ferdeghini M, Solimeo C, Bottoni A, Rossi L, Colato C & Zucchelli GC. Clinical relevance of highly sensitive assay in monitoring patients treated for differentiated thyroid cancer. Clinical Endocrinology 2007 67 434-441.
23. 131I whole-body scanning. Journal of Nuclear Medicine 2005 46 1473-1480.